Prnewswire·2026-01-12 13:09Core Insights - WuXi Biologics has launched PatroLab, a digital twin platform aimed at transforming bioprocess development and manufacturing through advanced analytics and predictive modeling [1][2] Group 1: PatroLab Overview - PatroLab integrates real-time process monitoring, Raman-based Process Analytical Technology (PAT), and predictive in-silico modeling to enhance process performance and minimize risks [1][2] - The platform aims to accelerate decision-making and shorten development timelines, ensuring high-quality biologics manufacturing [1][2] Group 2: Technological Innovations - The advanced Raman PAT system allows for real-time, non-invasive monitoring of over 40 key process performance and product quality attributes, moving away from traditional static testing [3] - PatroLab increases data density per batch by nearly 1,000 times compared to traditional methods, facilitating the application of Quality by Design (QbD) principles [4] Group 3: Process Improvement and Risk Management - The platform supports rapid chemical characterization of raw materials, enabling proactive interventions to reduce batch variations and ensure product consistency [5] - By utilizing data-driven and mechanistic modeling, PatroLab creates virtual bioprocess replicas, allowing for predictive decision-making and "what-if" scenario analysis [6][7] Group 4: Manufacturing Efficiency - PatroLab reduces process deviations and batch rejection rates through end-to-end monitoring aligned with critical quality attributes, improving overall success rates [9] - The platform enables dynamic, model-predictive control and automated strategies, enhancing efficiency and reliability in biomanufacturing [10] Group 5: Collaboration and Knowledge Management - PatroLab is integrated into WuXi Biologics' digital ecosystem, facilitating real-time data sharing and collaboration across teams for bioprocess development [11]